What lat­est wave of lay­offs means for biotech; Ra­dio­ther­a­py short­age; De­liv­er­ing on mR­NA's promis­es; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

Nom­i­na­tions are now open for a spe­cial re­port that will high­light the con­tri­bu­tions of LGBTQ+ bio­phar­ma lead­ers. Let us know who we should con­sid­er — our main ask is that you make the nom­i­na­tions per­son­al.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.